---
title: OMISAN S.p.A. vs Unither Pharmaceuticals
slug_a: omisan
slug_b: unither-pharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/omisan/unither-pharma
generated_by: BioBM Editorial AI
---

# OMISAN S.p.A. vs Unither Pharmaceuticals

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

OMISAN S.p.A. (omisan) is listed for cdmo. Italian maker of sterile ophthalmic medical devices, including eye drops, sprays, eyewashes, and contact lens solutions. Offers private label and CDMO manufacturing for ophthalmic multinationals, with preservative-free dispensing technologies.

Services: 1. Modalities: 0. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (1).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Unither Pharmaceuticals (unither-pharma) is listed for cdmo. Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.

Services: 11. Modalities: 0. Indications: 3. Locations: 4. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.